» Articles » PMID: 12446533

Cannabis Use and Mental Health in Young People: Cohort Study

Overview
Journal BMJ
Specialty General Medicine
Date 2002 Nov 26
PMID 12446533
Citations 265
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine whether cannabis use in adolescence predisposes to higher rates of depression and anxiety in young adulthood.

Design: Seven wave cohort study over six years.

Setting: 44 schools in the Australian state of Victoria.

Participants: A statewide secondary school sample of 1601 students aged 14-15 followed for seven years.

Main Outcome Measure: Interview measure of depression and anxiety (revised clinical interview schedule) at wave 7.

Results: Some 60% of participants had used cannabis by the age of 20; 7% were daily users at that point. Daily use in young women was associated with an over fivefold increase in the odds of reporting a state of depression and anxiety after adjustment for intercurrent use of other substances (odds ratio 5.6, 95% confidence interval 2.6 to 12). Weekly or more frequent cannabis use in teenagers predicted an approximately twofold increase in risk for later depression and anxiety (1.9, 1.1 to 3.3) after adjustment for potential baseline confounders. In contrast, depression and anxiety in teenagers predicted neither later weekly nor daily cannabis use.

Conclusions: Frequent cannabis use in teenage girls predicts later depression and anxiety, with daily users carrying the highest risk. Given recent increasing levels of cannabis use, measures to reduce frequent and heavy recreational use seem warranted.

Citing Articles

Examining the Relationship Between Cannabis Use and Mood, Anxiety, and Psychotic Symptoms in Psychiatric Patients with Severe Concurrent Mental Health and Substance Use Disorders Before and After Recreational Cannabis Legalization in Canada.

Thiessen K, Schutz C Cannabis. 2025; 7(3):90-105.

PMID: 39781555 PMC: 11705035. DOI: 10.26828/cannabis/2024/000258.


The Complex Relationship Between Cannabis Use and Mental Health: Considering the Influence of Cannabis Use Patterns and Individual Factors.

Sagar K, Gruber S CNS Drugs. 2025; 39(2):113-125.

PMID: 39753766 DOI: 10.1007/s40263-024-01148-2.


Cannabis use, oral dysbiosis, and neurological disorders.

Hazzard A, McCrorey M, Salman T, Johnson D, Luo Z, Fu X NeuroImmune Pharm Ther. 2025; 3(3-4):183-193.

PMID: 39741560 PMC: 11683879. DOI: 10.1515/nipt-2024-0012.


Long-Term Outcomes of Adolescent Outpatient Treatment for Substance Use Problems: Exploring the Co-occurrence of Mental Health and Substance Use Problems.

Boson K, Anderberg M, Wenneberg P, Vlasman S, Kapetanovic S, Dahlberg M Scand J Child Adolesc Psychiatr Psychol. 2024; 12(1):20240013.

PMID: 39717150 PMC: 11665878. DOI: 10.2478/sjcapp-2024-0013.


Quantitative analysis of cannabinoids and metabolites in oral fluid by volumetric absorptive microsampling combined with UHPLC-HRMS.

Thiebot P, Magny R, Martins P, Houze P, Bloch V, Vorspan F Anal Bioanal Chem. 2024; 417(2):345-360.

PMID: 39625516 DOI: 10.1007/s00216-024-05651-9.


References
1.
Troisi A, Pasini A, Saracco M, Spalletta G . Psychiatric symptoms in male cannabis users not using other illicit drugs. Addiction. 1998; 93(4):487-92. DOI: 10.1046/j.1360-0443.1998.9344874.x. View

2.
Hall W . Cannabis use and psychosis. Drug Alcohol Rev. 2005; 17(4):433-44. DOI: 10.1080/09595239800187271. View

3.
Paton S, Kessler R, Kandel D . Depressive mood and adolescent illicit drug use: a longitudinal analysis. J Genet Psychol. 1977; 131(2d Half):267-89. DOI: 10.1080/00221325.1977.10533299. View

4.
GREEN B, Ritter C . Marijuana use and depression. J Health Soc Behav. 2000; 41(1):40-9. View

5.
Linszen D, Dingemans P, Lenior M . Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry. 1994; 51(4):273-9. DOI: 10.1001/archpsyc.1994.03950040017002. View